Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Icade Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Icade kazanç ve gelirin sırasıyla yıllık 95.8% ve 4.7% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 115.9% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 5.6% olacağı tahmin edilmektedir.

Anahtar bilgiler

94.7%

Kazanç büyüme oranı

121.5%

EPS büyüme oranı

REITs kazanç büyümesi	45.3%
Gelir büyüme oranı	4.3%
Gelecekteki özkaynak getirisi	5.6%
Analist kapsamı	Good
Son güncelleme	02 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

ENXTPA:ICAD - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (EUR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	1,576	272	N/A	231	4
12/31/2025	1,544	177	N/A	237	4
12/31/2024	1,558	-206	N/A	230	4
6/30/2024	1,523	-953	265	265	N/A
3/31/2024	1,524	-1,121	251	251	N/A
12/31/2023	1,525	-1,289	238	238	N/A
9/30/2023	1,494	-1,116	317	317	N/A
6/30/2023	1,464	-944	397	397	N/A
3/31/2023	1,467	-657	319	319	N/A
12/31/2022	1,469	-370	242	242	N/A
9/30/2022	1,496	-61	N/A	N/A	N/A
6/30/2022	1,524	249	547	224	N/A
3/31/2022	1,586	324	538	377	N/A
12/31/2021	1,648	399	529	529	N/A
6/30/2021	1,640	280	-51	600	N/A
3/31/2021	1,534	178	34	625	N/A
12/31/2020	1,429	76	120	650	N/A
6/30/2020	1,458	259	-233	453	N/A
3/31/2020	1,485	278	-325	411	N/A
12/31/2019	1,512	298	-417	369	N/A
9/30/2019	1,587	235	-317	358	N/A
6/30/2019	1,662	173	-218	346	N/A
3/31/2019	1,717	165	-193	351	N/A
12/31/2018	1,773	156	-169	356	N/A
9/30/2018	1,714	137	-258	372	N/A
6/30/2018	1,655	118	-348	387	N/A
3/31/2018	1,642	142	N/A	362	N/A
12/31/2017	1,629	165	N/A	337	N/A
6/30/2017	1,596	106	N/A	255	N/A
3/31/2017	1,542	75	N/A	235	N/A
12/31/2016	1,487	45	N/A	215	N/A
6/30/2016	1,391	-101	N/A	309	N/A
3/31/2016	1,411	-144	N/A	307	N/A
12/31/2015	1,431	-187	N/A	305	N/A
6/30/2015	1,649	82	N/A	526	N/A
3/31/2015	1,687	116	N/A	506	N/A
12/31/2014	1,725	151	N/A	486	N/A
9/30/2014	1,683	111	N/A	342	N/A
6/30/2014	1,602	79	N/A	199	N/A
3/31/2014	1,540	103	N/A	184	N/A
12/31/2013	1,479	127	N/A	170	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: ICAD önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 1.2% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: ICAD önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: ICAD önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: ICAD şirketinin gelirinin (yıllık 4.7% ) French pazarından (yıllık 5.7% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: ICAD şirketinin gelirinin (yıllık 4.7% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: ICAD 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 5.6 %).

Icade Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased by 7.4% to €30.32

Price target decreased by 7.8% to €29.59

Price target decreased by 8.3% to €32.09

Price target decreased by 7.9% to €32.82

Consensus EPS estimates upgraded to €6.67 loss, revenue downgraded

Consensus EPS estimates fall by 69%

Recent updates

Price target increased by 7.4% to €30.32

First half 2024 earnings released: €2.38 loss per share (vs €6.80 loss in 1H 2023)

Now 23% undervalued after recent price drop

Now 21% undervalued

Now 20% undervalued

Price target decreased by 7.8% to €29.59

Price target decreased by 8.3% to €32.09

Price target decreased by 7.9% to €32.82

Dividend of €2.42 announced

Now 21% undervalued after recent price drop

Upcoming dividend of €2.42 per share

Icade, Annual General Meeting, Apr 19, 2024

Consensus EPS estimates upgraded to €6.67 loss, revenue downgraded

Consensus EPS estimates fall by 69%

Consensus EPS estimates fall by 63%

Icade to Report Q1, 2024 Results on Apr 22, 2024

Icade to Report First Half, 2024 Results on Jul 22, 2024

Icade to Report Fiscal Year 2023 Results on Feb 19, 2024

Icade(ENXTPA:ICAD) dropped from FTSE All-World Index (USD)

Price target decreased by 7.3% to €41.55

Consensus EPS estimates fall by 160%

Now 20% undervalued after recent price drop

Primonial REIM and Société Générale Assurances completed the acquisition of 63% stake in Icade Santé SAS from Icade (ENXTPA:ICAD) and its Minority Shareholders.

Upcoming dividend of €2.17 per share at 12% yield

Consensus estimates of losses per share improve by 75%

Vauban Infrastructure Partners and Icade (ENXTPA:ICAD) agreed to acquire A2A Coriance SAS.

Consensus EPS estimates fall by 17%, revenue upgraded

Oteis France Sas agreed to acquire AMO and EXPERTISE SANTE activity from Icade (ENXTPA:ICAD).

Consensus EPS estimates fall by 17%

Consensus estimates of losses per share improve by 16%

Consensus EPS estimates fall by 15%

An undisclosed buyer acquired Michigan Garden Project from Icade SA (ENXTPA:ICAD) for €108 million.

Icade SA (ENXTPA:ICAD) acquired Défense Parc complex in Nanterre Préfecture for €63 million.

Icade SA to Report Q1, 2023 Results on Apr 24, 2023

Icade SA to Report Fiscal Year 2022 Results on Feb 20, 2023

Consensus forecasts updated

Consensus forecasts updated

Elysées Pierre signed a bilateral preliminary agreement to acquire 16,000-Sq.m AXE 13 Office Building in Nanterre from Icade (ENXTPA:ICAD).

Investor sentiment deteriorated over the past week

Upcoming dividend of €2.10 per share

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Residences Le Logement Des Fonctionnaires SA signed a bilateral preliminary agreement to acquire Residual Residential Portfolio from Icade (ENXTPA:ICAD) for €49.9 million.

Icade (ENXTPA:ICAD) acquired 50.1% interest in M&A Group.

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Consensus forecasts updated

An unknown buyer completed the acquisition of Office building in Boulogne-Billancourt from Icade SA (ENXTPA:ICAD).

Consensus EPS estimates increase to €1.91

Consensus EPS estimates increase to €1.10

First half 2021 earnings released: EPS €2.52 (vs €0.07 in 1H 2020)

Consensus forecasts updated

Revenue beats expectations, earnings disappoint

A Look At Icade's (EPA:ICAD) Share Price Returns

New 90-day low: €55.50

Analysts update estimates

How Did Icade SA's (EPA:ICAD) 8.0% ROE Fare Against The Industry?

A pan-European fund dedicated to a German institutional investor managed by Aberdeen Standard Investments Limited acquired Two residential buildings in Rueil-Malmaison from Icade SA (ENXTPA:ICAD) for €14.6 million.

Icade SA (ENXTPA:ICAD) acquired Ad Vitam

Icade SA to Report Q1, 2021 Results on Apr 23, 2021

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

What Type Of Shareholders Make Up Icade SA's (EPA:ICAD) Share Registry?

New 90-day high: €68.20

Market bids up stock over the past week

New 90-day low: €42.96

New 90-day low: €48.00

Analysts lower EPS estimates to €1.11

New 90-day low - €54.25